Our research aimed to explore the role and basic mechanism of Gli1 in CAVD, to pave the way for the discovery of effective drugs in the treatment of CAVD. This evidence concerns the gene GLI1 and congenital bilateral aplasia of vas deferens from CFTR mutation.